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ABSTRACT.—The restoration or conservation of predators could reduce seroprevalences of
certain diseases in prey if predation selectively removes animals exhibiting clinical signs. We
assessed disease seroprevalences and blood parameters of 115 adult female elk (Cervus
elaphus) wintering on the northern range of Yellowstone National Park [YNP] during 2000–
2005 and compared them to data collected prior to wolf (Canis lupus) restoration (WR) in
1995 and to two other herds in Montana to assess this prediction. Blood parameters were
generally within two standard deviations of the means observed in other Montana herds
(Gravelly-Snowcrest [GS] and Garnet Mountain [GM]), but Yellowstone elk had higher
seroprevalences of parainfluenza-3 virus (95% CI YNP 5 61.1–78.6, GS 5 30.3–46.5) and
bovine-virus-diarrhea virus type 1 (95% CI YNP 5 15.9–31.9, GM 5 0). In comparisons
between pre-wolf restoration [pre-WR] (i.e., prior to 1995) seroprevalences with those post-
wolf restoration [post-WR] in Yellowstone, we found lower seroprevalences for some disease-
causing agents post-wolf restoration (e.g., bovine-virus-diarrhea virus type-1 [95% CI pre-WR
5 73.1–86.3, post-WR 5 15.9–31.9] and bovine-respiratory syncytial virus [95% CI pre-WR 5
70.0–83.8, post-WR5 0]), but similar (e.g., Brucella abortus [95% CI pre-WR5 0–4.45, post-WR
5 0–4.74] and epizootic hemorrhagic disease virus [95% CI pre-WR 5 0, post-WR 5 0]) or
higher for others (e.g., Anaplasma marginale [95% CI pre-WR 5 0, post-WR 5 18.5–38.7] and
Leptospira spp. [95% CI pre-WR 5 0.5–6.5, post-WR 5 9.5–23.5]). Though we did not detect
an overall strong predation effect through reduced disease seroprevalence using retrospec-
tive comparisons with sparse data, our reference values will facilitate future assessments of this
issue.
INTRODUCTION
The high mountains and plateaus of Yellowstone National Park provide summer range for
an estimated 10,000–25,000 elk (Cervus elaphus) from 8 herds. Most of these elk winter on
separate ranges outside the park, owing to snowfalls that accumulate to more than 3 m on
interior plateaus. These world-renowned herds provide significant visitor enjoyment and
benefits to local economies (e.g., hunting). However, they also have been implicated in the
transmission of diseases such as brucellosis (Brucella abortus), sarcoptic mange (scabies) and
septicemic pasteurellosis to wildlife and domestic livestock in Idaho, Montana and Wyoming
(Aguirre et al., 1995; Wolfe et al., 2002). These claims have led to proposals for eliminating
diseases such as brucellosis from elk in the Greater Yellowstone Area by capture, test and
slaughter (USDOI and USDA, 2000).
However, management proposals should consider the potential for selective predation to
reduce disease prevalence in ungulate herds through natural means (i.e., a sanitation
4 Corresponding author, present address: Mexican Wolf Reintroduction Project, PO Box 856, Alpine,
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effect). Yellowstone supports an intact large-predator complex, including black bears (Ursus
americanus), coyotes (Canis latrans), grizzly bears (U. arctos) and cougars (Puma concolor); and
wolves (C. lupus), which were reintroduced in 1995–96. Wolves increased rapidly and during
2000–2005 reached one of the highest densities recorded worldwide (Smith et al., 2003). Elk
comprised 89% of wolf kills during the winters of 1995–2005 (Smith et al., 2004) and elk in
the northern part of the park decreased by approximately 50% (White and Garrott, 2005).
Wolves and hunters each took 7–8% of adult cow elk annually (Evans et al., 2006). Bears and
coyotes were also significant predators of neonatal elk during this period (Barber et al.,
2005). If some diseases increase prey vulnerability, selective predation (Mech and Peterson,
2003) may reduce disease prevalence depending in part on the transmission dynamics of the
disease (i.e., animals compromised by an infectious agent are not always the most important
transmitters of the agent).
Some of the diseases summarized by Mech (1970) and (Mech et al., 1998) which
apparently make prey more vulnerable to wolf predation include actinomycosis (a severe
infection affecting jawbones), other skeletal diseases and disorders (e.g., arthritis), heavy
hydatid-tapeworm (Echinococcus granulosus) cyst infestations, and poor condition evidenced
by reduced marrow-fat suggesting some serious disease condition in the prey (unless there is
a lack of adequate food). However, no previous studies have examined disease prevalence in
prey pre- and post-wolf restoration. Yellowstone National Park presented this opportunity.
The National Research Council (NRC, 2002) recommended for Yellowstone that
‘‘Periodic surveillance for pathogens (including brucellosis) in wild ruminants in the
northern range should be continued and a more thorough understanding of population-
level threshold dynamics gained.’’ Our first objective was to collect data to create reference
values for selected pathogens and blood parameters in northern Yellowstone elk during
2000–2002 and 2005. Our second objective was to compare these seroprevalence data with:
(1) data from Yellowstone elk prior to wolf restoration; and (2) data from two other elk
herds in Montana to assess differences among areas and periods. We predicted the following
changes in disease seroprevalences after wolf restoration: (1) decreased seroprevalence in
certain diseases via wolves selectively removing elk with clinical manifestations of disease
which increased their vulnerability to predation (Murie, 1944; Mech, 1966; Fuller, 1966: 36;
see summary by Mech and Peterson, 2003:141); (2) decreased disease seroprevalence by
a reduction in overall elk numbers which may reduce disease transmission if elk
concentrations correspondingly change; and (3) potentially increased seroprevalence of
some diseases depending on elk-herding behavior following wolf restoration (Mao, 2003)
and, therefore, potentially increased disease transmission rate. Because elk in Yellowstone
were already at high densities prior to wolf restoration (White and Garrott, 2005), we did
not expect increased herding to be as important in disease dynamics compared to our first
two predictions. Therefore, we hypothesized an overall decrease in disease seroprevalence
following wolf restoration. Because the epidemiology (i.e., transmission dynamics, seasonal
variabilities, clinical manifestation of disease) of many diseases in wild elk remains only
partially understood (Depner et al., 1991; Aguirre et al., 1995; Frolich, 2000; NRC, 2002;
Thorne et al., 2002) specific predictions with respect to particular diseases were not
possible.
METHODS
Yellowstone National Park encompasses 8991 km2 of Wyoming, Montana and Idaho in
the western United States (44uN latitude and 110uW longitude). Our study area included
the winter range of northern Yellowstone elk, which consisted of 1520 km2 of foothills and
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valley bottoms along the Gardiner, Lamar and Yellowstone rivers. Nearly 1000 km2 of this
area was within Yellowstone National Park and the remainder was on Gallatin National
Forest, state and privately owned lands (Lemke et al., 1998). Annual counts of elk that
wintered on the northern range during 2000–05 ranged between 8335–14,539 (White and
Garrott, 2005). Descriptions of the climate, topography, vegetation and diverse predator-
prey complex of this range during our study were provided in White and Garrott (2005) and
the references cited therein.
We captured 115 adult female elk ($1-y old) using net-guns from helicopters during
either Feb. or Mar. of 2000–02 and 2005 as described by Cook et al. (2004). Helicopter
chases of elk generally lasted less than 1 min. Animals were handled in compliance with the
requirements of the Institutional Animal Care and Use Committee for the University of
Minnesota and guidelines recommended by the American Society of Mammalogists (Animal
Care and Use Committee, 1998). Biologists drew approximately 50 ml of blood (,5 min
after netting the elk) by puncture of the jugular vein using 16 or 18 gauge 1K0 needles and
a 60 mL syringe. We placed blood in sterile, 10-mL, serum tubes and centrifuged the blood
within 4 h of collection. We stored serum in cryovials (2–5 mL) in a freezer (260 C) within
1–8 h. At the completion of captures each winter, serum samples were shipped overnight
with ice packs to the Wyoming State Veterinary Laboratory (WSVL; Laramie, WY, USA). We
also collected about 5–10 fecal pellets from the rectum of the animal using a gloved hand.
We froze fecal samples and shipped them overnight with ice packs to the WSVL for
pregnancy tests for all years and for parasites during 2001–02 (Baermann’s test and eggs and
oocysts). During 2001–02 we also collected one nasal swab sample from each elk using either
the Baxter Healthcare Culturette System (Deerfield, Illinois, USA) or the Becton/Dickinson
BBL CultureSwab (Sparks, Maryland, USA) for bacteria and virus isolations. Nasal samples
were maintained at 5uC and shipped within 24 h to the WSVL for bacterial evaluation. Both
the fecal and nasal swab tests were considered ‘‘gold standard’’ tests (Thrusfield, 2005) and
actual disease-causing agents were detected. We also estimated age by tooth annuli (the
fourth incisor during 2000 and the upper canine during 2001–02 and 2005), nutritional
condition (during 2000–02) and pregnancy status (protein B specific for pregnancy via
radioimmunoassay, BioTracking, Moscow, Idaho, USA) (Cook et al., 2004). Lactation and
body fat data were collected during 2000–02 (Cook et al., 2004).
Whole-blood and serum were sent to WSVL for analyses. We tested sera for presence of
antibodies (rather than the actual pathogen itself) against Anaplasma marginale, border-
disease virus, bovine-respiratory syncytial virus, bovine-virus-diarrhea virus type 1 and type 2,
Brucella abortus, Chlamydophilia, epizootic-hemorrhagic-disease virus, infectious-bovine
rhinotracheitis virus, Leptospira spp., parainfluenza-3 virus and Mycobacterium paratuberculosis
during 2000–02, 2005 using tests indicated in Table 1. The WSVL summarized A. marginale,
B. abortus, Chlamydophilia, epizootic-hemorrhagic-disease virus and M. paratuberculosis results
as positive or negative (all evaluations were bovine-based except for B. abortus tests which
were elk-validated and none of the tests were considered ‘‘gold standard’’ tests; Thrusfield,
2005). Leptospirosis exposure was evaluated at 1:100 dilution. Other disease titers were
considered as follows: .1:16, exposed to the disease; 5 1:16, possibly exposed; and ,1:16,
not exposed (except for parainfluenza-3 virus because these titers were not reported in 1:4
dilutions and, therefore, these titers were interpreted as follows: .1:20, exposed; 5 1:20,
possibly exposed; and ,1:20, not exposed). After discussions with WSVL staff we set these
conservative titer categories to avoid falsely identifying an animal as exposed to disease (see
Goyal et al., 1988). We constructed 95% confidence intervals for seroprevalence following
Thursfield (2005).
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Hematology was analyzed using the Idexx QBC VetAutoread (QBC Diagnostics Inc., State
College, Pennsylvania, USA) and included hemoglobin, packed-cell volume, platelets, white-
blood-cell counts and differentials including segmented neutrophils, banded neutrophils,
lymphocytes, monocytes, eosinophils and basophils (slides prepared at the WSVL), and
mean corpuscular hemoglobin concentration. Samples from 2002 and 2005 were analyzed
for serum concentrations of urea nitrogen, total protein, albumin, calcium, magnesium,
inorganic phosphorus, alkaline phosphatase, creatine kinase, aspartate aminotransferase,
gamma glutamyltransferase, lactate dehydrogenase, gamma globulins and glucose using the
Idexx VetTest Chemistry Analyzer prior to 2003 (Idexx Laboratories Inc., Westbrook,
Maine, USA) and the VetEx Autoanalyzer after 2003 (Alfa Wasserman, West Caldwell, New
Jersey, USA). Total serum thyroxine was analyzed using the VetEx Autoanalyzer (Alfa
Wasserman, West Caldwell, New Jersey, USA). Trace minerals including zinc, copper, iron,
manganese and molybdenum from serum and selenium from blood were analyzed by
TABLE 1.—Disease seroprevalence tests performed on blood sampled from adult, female elk on
Yellowstone’s northern range during winter 2000–02 and 2005. Unless otherwise noted all tests were
conducted at the Wyoming State Veterinary Lab (WSVL)
Diseasea
Year(s) Sample(s)
Collected
Year(s) Sample(s)
Analyzed Testb,c Comments
ANA 2000, 2002, 2005 2005 ELISA –
BDV 2001, 2002 2001, 2002 SN –
BRSV 2000, 2005 2005 SN –
2001, 2002 2001, 2002 SN –
BVD-1 2000, 2005 2005 SN –
2001, 2002 2001, 2002 SN –
BVD-2 2001, 2002 2001, 2002 SN –
BRU 2000–2002, 2005 2000–2002, 2005 CARD, SPT,
RIVd
–
Chlamydophilia 2000 2000 SN Tested at the Texas Veterinary
Medical Diagnostic
Laboratory System,
Amarillo, TX
2001, 2002 2001, 2002 SN Tested at the WSVL
EHDV 2001, 2002 2001, 20002 AGID –
IBR 2000, 2005 2005 SN –
2002 2002 SN –
LEPTO 2000, 2005 2005 MAT –
2001, 2002 2001, 2002 MAT –
PI-3 2000–2002, 2005 2000–2002, 2005 SN –
PTB 2000, 2005 2005 ELISA –
2001, 2002 2001, 2002 AGID –
a ANA, Anaplasma marginale; BDV, border-disease virus; BRSV, bovine-respiratory syncytial virus; BVD-
1 and BVD-2, bovine-virus-diarrhea virus type 1 and 2; BRU, Brucella abortus; EHDV, epizootic-
hemorrhagic-disease virus; IBR, infectious-bovine rhinotracheitis virus; LEPTO, Leptospirosis spp.; PI-3,
parainfluenza-3 virus; PTB, Mycobacterium paratuberculosis
b ELISA, enzyme-linked immunosorbent assay; SN, serum neutralization; CARD, card test; STP,
standard-plate test; RIV, rivanol-precipitation-aggultination; AGID, standard agar-gel immunodiffusion;
MAT, microscopic agglutination test
c Tests for Brucella abortus were USDA/APHIS validated for elk. The other tests were bovine-validated
d Morton et al. 1981
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inductively coupled plasma-mass spectrometry with the Elan 6100 (PerkinElmer, Norwak
Connecticut, USA).
We compared disease seroprevalences and blood parameters during winters 2000–02, and
2005 with values reported for: (1) 143 male and female (unknown sex ratio) elk . 2-y old
from northern Yellowstone that migrated outside the park and were harvested by hunters
prior to wolf restoration (Aguirre et al., 1995); (2) 209 female elk $ 3-y old (blood
parameter comparisons) and 913 female and male elk (disease seroprevalence compar-
isons) of western Montana captured in the Gravelly-Snowcrest Mountains of Montana by
helicopter net driving, drug immobilization, darting from a helicopter and a hand-held net
gun fired from a helicopter during 1984–1996 (Hamlin and Ross, 2002); (3) 28 adult-female
elk captured from the Garnet Mountains in west-central Montana with ballistic nets fired
from a helicopter during 2002–04 (2006; M. Thompson, Montana Fish, Wildlife, and Parks,
pers. comm.); and (4) standards for captive female elk . 2-y old reported by the
International Species Information System from 19 member institutions (ISIS, 2002).
We used two factorial analysis of variance (ANOVA) models to assess relationships
between disease seroprevalence or parasite values for northern Yellowstone elk during
2000–05 and covariates including capture year, age (2–9 y old, and $10-y old) and body fat
(,5%, 5–10% and .10%; during 2000–2002). One ANOVA model used all the available
data for a particular disease or parasite value and capture year and age covariates and a 2nd
model was limited in years by the addition of body-fat data.
We used factorial ANOVA to assess relationships between individual blood parameters for
northern Yellowstone elk during 2000–2005 and covariates including capture year,
pregnancy status, age (2–9 y old and $10-y old), body fat (,5%, 5–10% and .10%), and
lactation status. We converted all continuous variables to logarithm base 10 to stabilize
variance and lessen the impact of extremes for ANOVA analyses. We first added 0.5 to each
monocyte, banded neutrophil, and eosinophil value because these covariates included
numerous zero values (Krebs, 1999). We obtained geometric means by back-transforming
the logarithms and created three factorial ANOVA models for each blood parameter. One
model used all the available data, while a 2nd model was temporally limited to 2000–02 data
by the inclusion of body-fat data and a 3rd model was similarly limited by the inclusion of
lactation data. Only 2-way interactions were assessed among covariates due to sample-size
limitations. We performed all analyses using Statistica v.6 (StatSoft, Tulsa, Oklahoma, USA)
and considered differences significant at a # 0.05.
RESULTS
We captured and sampled 115 adult female elk on the northern range of Yellowstone
during winters 2000–02 and 2005. Seroprevalences and 95% confidence intervals follow:
bovine-virus-diarrhea virus type 1, 24% (16–32%); bovine-virus-diarrhea type 2, 6% (0–12%),
infectious-bovine rhinotracheitis virus, 4% (0–8%); parainfluenza-3 virus, 70% (61–79%);
bovine-respiratory syncytial virus, 0%; Brucella abortus, 2% (0–5%); Leptospira spp., 17% (10–
23%); Anaplasma marginale, 29% (18–39%); Mycobacterium paratuberculosis, 0%; and epizootic
hemorrhagic virus, 0% (Table 2). Presence of nasal bacteria (e.g., Enterobacter, Streptomyces) was
low (4%, 95% CI 5 0–9%), and parasites were detected in 31% (95% CI 5 18–45%) of fecal
samples using Baermann’s test and in 57% (95% CI5 42–71%) of samples examined for eggs
and oocysts (Table 3). No disease or parasite value was related to age or body fat (Table 4).
Disease seroprevalences for northern Yellowstone elk 5–10 y after wolf restoration [post-
WR] compared to those prior to wolf restoration [pre-WR] were substantially lower for
bovine-virus-diarrhea virus type 1 [95% CI pre-WR 5 73.1–86.3, post-WR 5 15.9–31.9] and
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bovine-respiratory syncytial virus [95% CI pre-WR 5 70.0–83.8, post-WR 5 0]) while similar
(e.g., Brucella abortus [95% CI pre-WR 5 0–4.45, post-WR 5 0–4.74] and epizootic
hemorrhagic disease virus [95% CI pre-WR 5 0, post-WR 5 0]) or higher for others (e.g.,
Anaplasma marginale [95% CI pre-WR5 0, post-WR5 18.5–38.7] and Leptospira spp. [95% CI
pre-WR 5 0.5–6.5, post-WR 5 9.5–23.5]) (Table 2). Compared to other Montana elk herds
(Garnet Mountains [GM] and Gravelly-Snowcrest [GS]) 95% confidence intervals for
disease seroprevalences of northern Yellowstone elk following wolf restoration were higher
for parainfluenza-3 virus (95% CI YNP 5 61.1–78.6, GS 5 30.3–46.5) and bovine-virus-
diarrhea virus type 1 (95% CI YNP 5 15.9–31.9, GM 5 0) (Table 2).
Pregnant elk had lower monocytes (P 5 0.05, F1,42 5 4.20) and higher albumin, calcium,
gamma globulins, magnesium, and protein (all P # 0.04, F1,28 $ 4.71). No blood values
were related to lactation or body fat after accounting for capture year, age and pregnancy,
except for segmented neutrophils which varied by the interaction between age and body fat
(P 5 0.02, F2,35 5 4.57) (Tables 5, 6).
DISCUSSION
The values for selected blood parameters for northern Yellowstone elk during 2000–02
and 2005 were generally similar to those from the Gravelly-Snowcrest and Garnet Mountains
TABLE 3.—Other disease, bacteria, parasite, and virus profiles [% positive, SE (no. positive/n) and %
possibly exposed, SE (no. possibly exposed/n)] evaluated in Yellowstone’s northern-range, adult female
elk during winters 2000–02 and 2005
Pathogen
YNP elk
positive
YNP elk possibly
exposed Comments
Border disease virus 7.8, 3.8 (4/51) 13.7, 4.8 (7/51) –
Chlamydophilia 0.0, 0.0 (0/96) 9.4, 3.0 (9/96) –
Bacteria (nasal swab) 4.0, 2.8 (2/50) – 1 Enterobacter and 1 Streptomyces
detection
Viruses (nasal swab) 0.0, 0.0 (0/52) – –
Parasites (fecal)
Baermann’s test 31.1, 6.9 (14/45) – Mean lungworm larvae/gm 5 1.43; 0.88
SD; range 0–3.46
Eggs & oocysts 56.5, 7.3 (26/46) – Various Eimeria (also non-pathogenic),
small Trichostrongylids, Moniezia,
Trichuris, and mites detected
TABLE 4.—Reproductive and condition characteristics (mean, SE, n) [min, max] of adult, female elk
on Yellowstone’s northern range during winters 2000–2002 and 2005
Year Age (yr)
Proportion
Pregnant
Proportion Currently
Lactating % Fat
2000a 7.56 (0.60, 42) [1, 15] 0.84 (0.06, 43) – 8.85 (0.50, 40) [1.79, 14.32]
2001a 11.12 (0.80, 28) [4, 18] 0.78 (0.08, 28) 0.09 (0.06, 23) 9.78 (0.80, 28) [1.80, 16.55]
2002a 8.75 (0.79, 24) [1, 15] 0.83 (0.08, 23) 0.17 (0.08, 24) 10.14 (0.75, 24) [2.94, 15.03]
2005 8.32 (0.79, 17) [2.5, 16] 0.94 (0.06, 17) – –
a Means for 2000–2002 were also reported by Cook et al. 2004. The differences in reported mean ages
are due to interpretation of values such as ‘‘10+’’ from teeth annuli. For our analysis, we disregarded any
‘‘+’’ associated with estimated age
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herds, with some notable exceptions. Northern Yellowstone elk had lower mean serum urea
nitrogen than elk from the Gravelly Snowcrest Mountains, the Garnet Mountains and ISIS
standards. Serum urea nitrogen (SUN) is an indicator of protein quality in the diet and has
been related to nutritional condition in white-tailed deer (DelGiudice et al., 1987). Renal
disease and hydration status can also impact SUN (Coles, 1980; DelGiudice et al., 1987).
Isolated interpretation of SUN is not possible as moderately high levels may indicate
increasing levels of dietary protein intake (Cook, 2002), while diets with very high energy
intake may have very low levels of serum urea nitrogen due to the rumen microbes more
efficiently utilizing the proteins and thus, producing less urea (Harder and Kirkpatrick,
1994). Northern Yellowstone elk also had reduced lymphocytes compared to elk from the
Garnet Mountains. Lymphocytes are white blood cells important in cell-mediated (T-cells)
and humoral (B-cells) immune responses and both increases and decreases in lymphocytes
can be signs of disease (Tizard, 1992). Thus, this finding alone cannot be interpreted to
indicate either herd was in better overall condition.
Northern Yellowstone elk had higher seroprevalences of parainfluenza-3 virus, bovine-virus-
diarrhea virus types 1 and 2 and brucellosis compared to those from the Gravelly-Snowcrest
and Garnet Mountains herds. With greater wolf densities in northern Yellowstone, elk herd
dynamics following wolf restoration may actually increase disease transmission depending on
the specific epidemiology of these diseases. During winter northern Yellowstone elk were
found in larger groups following wolf restoration (Mao, 2003), possibly because this may
reduce predation risk via the dilution effect (Hamilton, 1971) and allow elk to more easily
detect wolves through increased vigilance (Pulliam, 1973). However, aerial survey data from
more recent research indicates that at least in some areas elk are found in smaller groups
following wolf restoration (P. J. White, National Park Service, unpubl. data). Because elk
grouping following wolf restoration is not fully understood, we cannot reliably attribute
increased disease seroprevalence to increased elk herding.
Disease seroprevalences for northern Yellowstone elk were substantially lower 5–10 y
following wolf restoration for bovine-virus-diarrhea virus type 1 and bovine-respiratory
syncytial virus, but similar for Brucella abortus and epizootic hemorrhagic disease while
higher for Anaplasma marginale and Leptospira spp. Determining whether wolves (through
direct impacts via predation and/or indirect impacts through elk behavioral changes)
caused these changes in elk disease seroprevalence would require substantially more
knowledge of the epidemiology of each disease. Because only limited information is
available about disease transmission dynamics and clinical manifestations in wild elk only
plausible inferences are possible and causation cannot be determined.
For examples, parainfluenza-3 viruses cause mild respiratory disorders in domestic cattle
and sheep that serve as initiators for secondary infections of Pasteurella spp., which can result
TABLE 5.—Blood parameters of adult, female elk on Yellowstone’s northern range during winters
2000–2002 and 2005 compared to age, pregnancy, lactation and body fat
Blood characteristic Elk characteristic P Means (95% CI, n)
Segmented neutrophils
(%)
age 3 body fat 0.02 age 2–9; body fat ,5% 5 46.48 (36.24–59.61, 3),
age 2–9; body fat 5–10% 5 22.36 (12.92–38.72, 8),
age 2–9; body fat .10% 5 23.15 (17.30–30.99, 15),
age 10+; body fat ,5% 5 26.84 (13.17–54.66, 5),
age 10+; body fat 5–10% 5 41.19 (30.53–55.57, 6),
age 10+; body fat .10% 5 34.62 (29.82–40.20, 14)
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in bacterial pneumonia (Martin, 1996; Storz et al., 2000). Whether this virus causes clinical
symptoms in wild elk remains unknown. However, if elk exhibit respiratory difficulties, it is
easy to imagine them being predisposed to wolf predation during a chase. Bovine-virus-
diarrhea virus causes enteritis, mucosal disease, infections, and respiratory and reproductive
disorders in cattle (Baker, 1995), though experimentally inoculated non-pregnant elk
showed no clinical signs and remained healthy for .50 d post inoculation (Tessaro et al.,
1999). Therefore, if the lack of clinical signs in non-pregnant elk is similar in wild elk
(including those pregnant) then it appears unlikely that elk infected with this virus would
face increased vulnerability to wolf predation. Regarding anaplasmosis, significant clinical
disease in elk has not been reported (mild anemia followed by recovery has been observed;
Smits, 1991), although in cattle the disease can cause anemia, jaundice, and possibly death
(Thorne et al., 2002). While clinical signs of leptospirosis have been detected in captive red
deer, only serologic evidence of infection has been reported in elk (Thorne et al., 2002).
Clinical signs other than death may include bloody urine and kidney disease, hemolysis and
jaundice, and depression (Thorne et al., 2002). If wild elk infected with Leptospira spp.
exhibit clinical signs similar to captive red deer, it is conceivable that they may be vulnerable
to increased predation by wolves. In contrast, epizootic hemorrhagic disease produced only
mild fever in clinical trials of infected wapiti (Smits, 1991), which likely would not increase
vulnerability of prey to wolf predation. Elk infected with Mycobacterium paratuberculosis may
show non-specific clinical signs including poor weight gain and poor shedding of hair coat
and just prior to death rapid weight loss and diarrhea may occur (Smits, 1991). Given these
clinical manifestations, elk with paratuberculosis may be more vulnerable to wolf predation.
Similarly, it is possible that wolves may select for elk with brucellosis infections, at least in
chronic cases, because these cases may cause bursitis, synovitis, and arthritis resulting in
lameness (Thorne et al., 1978; Herriges et al., 1989). However, it is unclear whether this
selection would result in a detectable decrease of seroprevalence because elk without
chronic cases do not exhibit these symptoms. Also, elk interactions with bison in
Yellowstone are important because Yellowstone bison have 50–60% seroprevalences of
brucellosis (Ferrari and Garrott, 2002). Our results suggest the seroprevalence of brucellosis
has not appreciably increased in Yellowstone elk during the past decade. Seroprevalence
during 2000–2005 was 2% (95% CI 5 0–4.74) compared to 1% (95% CI5 0–1%) in hunter-
killed elk of both sexes sampled during 1991–1995 from 3 areas of Wyoming and Montana
adjacent to the park (Rhyan et al., 1997) and 3% (95% CI 5 0–6%) in central Yellowstone
adult female elk during 1996–1998 (Ferrari and Garrott, 2002). These seroprevalences are
much lower than those documented among elk that used feedgrounds at the National Elk
Refuge in Wyoming using similar tests to detect antibodies against Brucella abortus (25%,
95% CI 5 20–31 as cited in Table 1 of Ferrari and Garrott, 2002).
Thirty-one percent of northern Yellowstone elk tested positive for lungworm compared to
9–43% during the 1960s (Barrett and Worley, 1966; Greer, 1968) and ,20% during 1989–
1995 (Foos, 1997; Rhyan et al., 1997). Parasite load can affect vulnerability to predation and
intraspecific competition (Mech, 1966; Davies, 1978; Anderson, 1979; Holmes, 1982). The
prevalence of lungworm infection during 2000–2005 was not remarkably high (31%, 95% CI
5 18–45%) and the mean larvae/gm (1.43; 0.88 SD) was moderate (Table 3). However, the
relatively low intensity of infection could increase in future years given the current
prevalence of approximately 31%.
Five–10 y after wolf restoration, disease seroprevalences for northern Yellowstone elk were
substantially lower for bovine-virus-diarrhea virus type 1 and bovine-respiratory syncytial
virus, but similar for Brucella abortus and higher for Anaplasma marginale and Leptospira spp.
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Thus, our prediction that selective predation by wolves would reduce disease prevalence was
only partly supported. For some diseases (e.g., anaplasmosis, bovine-viral-diarrhea,
leptospirosis and epizootic hemorrhagic disease) wild elk may not exhibit clinical symptoms
that would increase their vulnerability to wolf predation or they may only show clinical signs
years after infection (e.g., bovine tuberculosis, Thorne et al., 2002). If we assume that
a particular disease leads to deficiencies that are exploitable by wolves, we may expect
disease prevalence to decrease as a result of wolf selective predation. However, as discussed
above, diseases may potentially be more readily transmitted between elk following wolf
restoration if elk grouping behaviors are significant to a particular disease’s dynamics.
Depending on the transmission dynamics of A. marginale and Leptospira spp. in wild elk, this
may explain why we observed higher prevalences in elk following wolf restoration.
Further complications in interpreting our results arise because of the limited specificity
(proportion of true negatives that are detected) and sensitivity (proportion of true positives
that are detected) of the disease tests themselves (in part because most of the tests we used
were bovine-validated and not ‘‘gold standards’’) (Thrusfield, 2005). Some of the difference
in comparisons between pre- and post-wolf seroprevalences may potentially be attributed to
different tests and methods such as titer level interpretation (see Table 2). Additionally, our
comparisons were hampered by limited overlap in the pathogens surveyed. Nevertheless,
the fact that post-wolf seroprevalence for some diseases were so much lower suggests that
wolves could be selecting individuals with those diseases and reducing their prevalence or
reducing the overall herd sufficiently to reduce the transmission of this disease and
therefore, the prevalence. Certainly this finding could form a valuable hypothesis for other
studies to test.
This was the first detailed assessment of disease seroprevalences and blood profiles of elk in
Yellowstone and, as a result, there were only sparse data available for comparison. Our reference
values will facilitate more rigorous future evaluations of potential predator ‘‘sanitation’’ effects,
especially when the epidemiology of these diseases in wild prey is more fully understood.
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